二尖瓣脱垂修复:胸腔镜微创与传统入路的比较
本研究对比2012至2020年因二尖瓣脱垂致重度原发性二尖瓣反流接受修复术的患者,胸腔镜组188例、传统胸骨切开组112例。经倾向性评分匹配后,胸腔镜组机械通气时间和重症监护室停留时间更短、术后血红蛋白更高,但体外循环和主动脉阻断时间更长;两组死亡率、出院时二尖瓣反流程度及随访期间生存、修复失败和再干预无差异。
要点
- 胸腔镜组机械通气9小时 vs 传统组15小时,重症监护室停留41小时 vs 65小时。
- 胸腔镜组术后血红蛋白11 mg/dl vs 传统组10.2 mg/dl。
- 胸腔镜组体外循环和主动脉阻断时间分别延长30分钟和17分钟。
核心结论
- 微创二尖瓣修复可用于多数二尖瓣脱垂患者,不损害结局、修复率或耐久性,同时提供更短的机械通气和重症监护室停留时间及更少失血。
研究设计与样本
- 回顾性分析2012至2020年所有因二尖瓣脱垂致重度二尖瓣反流接受手术的连续患者,按所用入路分组,共300例,胸腔镜组188例、传统胸骨切开组112例,采用倾向性评分匹配(1:1,最近邻)校正基线差异。
主要发现
- 匹配前胸腔镜组患者更年轻,体重指数、纽约心脏协会心功能分级和EuroSCORE II更低。
- 匹配后胸腔镜组机械通气9小时 vs 传统组15小时,重症监护室停留41小时 vs 65小时,术后血红蛋白11 mg/dl vs 10.2 mg/dl(胸腔镜组更高)。
- 胸腔镜组体外循环和主动脉阻断时间分别延长30分钟和17分钟。
- 两组死亡率、出院时二尖瓣反流程度、随访期间生存率、修复失败和再干预均无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Surgical repair remains the best treatment for severe primary mitral regurgitation (MR). Minimally invasive mitral valve surgery is being increasingly performed, but there is a lack of solid evidence comparing thoracoscopic with conventional surgery. Our objective was to compare outcomes of both approaches for repair of leaflet prolapse. METHODS: All consecutive patients undergoing surgery for severe MR due to mitral prolapse from 2012 to 2020 were evaluated according to the approach used. Freedom from mortality, reoperation and recurrent severe MR were evaluated by Kaplan-Meier method. Differences in baseline characteristics were adjusted with propensity score-matched analysis (1:1, nearest neighbour). RESULTS: Three hundred patients met inclusion criteria and were divided into thoracoscopic (N = 188) and conventional (sternotomy; N = 112) groups. Unmatched patients in the thoracoscopic group were younger and had lower body mass index, New York Heart Association class and EuroSCORE II preoperatively. After matching, thoracoscopic group presented significantly shorter mechanical ventilation (9 vs 15 h), shorter intensive care unit stay (41 vs 65 h) and higher postoperative haemoglobin levels (11 vs 10.2 mg/dl) despite longer bypass and cross-clamp times (+30 and +17 min). There were no differences in mortality or MR grade at discharge between groups nor differences in survival, repair failures and reinterventions during follow-up. CONCLUSIONS: Minimally invasive mitral repair can be performed in the majority of patients with mitral prolapse, without compromising outcomes, repair rate or durability, while providing shorter mechanical ventilation and intensive care unit stay and less blood loss.
引用
- Ascaso M, Sandoval E, Muro A, et al. Repair of mitral prolapse: comparison of thoracoscopic minimally invasive and conventional approaches. Eur J Cardiothorac Surg. 2023. PMID: 37354520. doi:10.1093/ejcts/ezad235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。